Elizabeth Brem

picture of Elizabeth  Brem

Assistant Professor, Medicine
School of Medicine

B.S., Canisius College, 2006, Biochemistry


M.D., SUNY Buffalo School of Medicine, 2010

Phone: (714) 456-5164
Email: ebrem@uci.edu

University of California, Irvine
101 City Drive South, Bldg 56
Room 231
Mail Code: 4061
Orange, CA 92848
Research Interests
lymphoma, Bcl2 family, apoptosis
Academic Distinctions
2018 Lymphoma Research Foundation Lymphoma Clinical Research Mentoring Program
2017 National Institutes of Health Clinical Loan Repayment Program
2017 Society of Hematologic Oncology (SoHo) Travel Grant
2016 UC Irvine American Cancer Society Seed Grant Award
2013 ASH Abstract Achievement Award
2012 ASH Trainee Research Award
2010 Alpha Omega Alpha National Honor Society
2007 ASH Trainee Research Award
Publications
Robertson JJ, Brem E, and Koyfman A. The Acute Hemolytic Anemias: The Importance of Emergency Diagnosis and Management. J Emerg Med. E pub 10 April 2017.
 
Brem EA and Letai AG. BOK: Oddball of the BCL-2 Family. Trends in Cell Biology. 2016;26(6)389-90.
Brem E and Davids M. Is Bcl-2 a valid target in the treatment of indolent non-Hodgkin lymphoma? Leukemia and Lymphoma. 2014;55(12):2675-2677.
Brem E, Koyfman A, Foran M. Review of Recently Approved Alternatives to Anticoagulation with Warfarin for Emergency Clinicians. J Emerg Med. 2013;45(1):143-9.
Koyfman A, Brem E, and Chiang V. Thrombotic Thrombocytopenic Purpura. Pediatric Emergency Care. 2011;27:1085-1091.
Brem E, Thudium K, et al. Obatoclax possesses a dual Mechanism of action and potentiates the anti-tumor effects of rituximab or chemotherapy in rituximab-sensitive and -resistant lymphomas. British Journal of Haematology. 2011;153:599-611.
Professional Societies
American Society of Hematology
American Society of Clinical Oncology
American Association of Cancer Research
Alpha Omega Alpha
University of California Hematologic Malignancies Consortium
Other Experience
Internal Medicine Resident
Beth Israel Deaconess Medical Center/Harvard Medical School 2010—2013

Hematology/Oncology Fellow
Beth Israel Deaconess Medical Center/Harvard Medical School 2013—2016

Last updated
03/19/2018